Preliminary study detecting of plasma soluble PD-L1 in the patients with advanced lung cancer

Preliminary study detecting of plasma soluble PD-L1 in the patients with advanced lung cancer - soluble PD-L1 with advanced lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014760

Enrollment

Registered

2014-08-30

Start date

2014-08-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criterion of the present study is the patients who treated with chemotherapy at Komagome Hospital. Before being underwent chemotherapy, the patients examined blood sample with tube (or EDTA) contains sodium heparin of the 4mL. Then, collected blood samples (upto 32 samples) are exploratory checked for soluble PD-L1 whether it could be detectable or not at Tokyo Jikei University.

Exclusion criteria

Exclusion criteria: Other than that above

Design outcomes

Primary

Measure	Time frame
To detect whether soluble PD-L1 is detectable or not in the plasma of patients with advanced lung cancer (before first-line chemotherapy or day after last day of the chemotherapy)	—

Countries

Japan

Contacts

Public ContactYusuke Okuma

Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Department of Thoracic Oncology and Respiratory Medicine

y-okuma@cick.jp03-3823-2101

Outcome results